Pascal and Francis Bibliographic Databases

Help

Export

Selection :

Permanent link
http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=20207363

A novel liposomal irinotecan formulation with significant anti-tumour activity : Use of the divalent cation ionophore A23187 and copper-containing liposomes to improve drug retention

Author
RAMSAY, Euan1 2 ; ALNAJIM, Jehan1 ; ANANTHA, Malathi1 ; ZASTRE, Jason1 ; HONG YAN1 ; WEBB, Murray1 ; WATERHOUSE, Dawn1 3 ; BALLY, Marcel1 3 4
[1] Department of Advanced Therapeutics, BC Cancer Agency, BC, Canada
[2] School of Pharmacy, University of Tasmania, Tasmania, Australia
[3] Faculty of Pharmaceutical Sciences, University of British Columbia, BC, Canada
[4] Department of Pathology and Laboratory Medicine, University of British Columbia, BC, Canada
Source

European journal of pharmaceutics and biopharmaceutics. 2008, Vol 68, Num 3, pp 607-617, 11 p ; ref : 63 ref

ISSN
0939-6411
Scientific domain
Pharmacology drugs
Publisher
Elsevier Science, Amsterdam
Publication country
Netherlands
Document type
Article
Language
English
Author keyword
A23187 Copper In vivo Irinotecan Liposome
Keyword (fr)
Anticancéreux Cation Cuivre Formulation In vivo Irinotécan Liposome Médicament Rétention Technologie pharmaceutique Camptothécine dérivé DNA topoisomerase Enzyme Inhibiteur de la topoisomérase I Inhibiteur enzyme Isomerases
Keyword (en)
Antineoplastic agent Cations Copper Formulation In vivo Irinotecan Liposome Drug Retention Pharmaceutical technology Camptothecin derivatives DNA topoisomerase Enzyme Topoisomerase I inhibitor Enzyme inhibitor Isomerases
Keyword (es)
Anticanceroso Cation Cobre Formulación In vivo Irinotecán Liposoma Medicamento Retención Tecnología farmacéutica Camptothecin derivado DNA topoisomerase Enzima Inhibidor topoisomerase I Inhibidor enzima Isomerases
Classification
Pascal
002 Biological and medical sciences / 002B Medical sciences / 002B02 Pharmacology. Drug treatments / 002B02A General pharmacology / 002B02A03 Pharmaceutical technology. Pharmaceutical industry

Discipline
General pharmacology
Origin
Inist-CNRS
Database
PASCAL
INIST identifier
20207363

Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS

Access to the document

Searching the Web